Sari H. Pakkanen

2.2k total citations
40 papers, 1.3k citations indexed

About

Sari H. Pakkanen is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Food Science. According to data from OpenAlex, Sari H. Pakkanen has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 12 papers in Public Health, Environmental and Occupational Health and 11 papers in Food Science. Recurrent topics in Sari H. Pakkanen's work include Viral gastroenteritis research and epidemiology (11 papers), Travel-related health issues (11 papers) and Salmonella and Campylobacter epidemiology (11 papers). Sari H. Pakkanen is often cited by papers focused on Viral gastroenteritis research and epidemiology (11 papers), Travel-related health issues (11 papers) and Salmonella and Campylobacter epidemiology (11 papers). Sari H. Pakkanen collaborates with scholars based in Finland, Sweden and Switzerland. Sari H. Pakkanen's co-authors include Anu Kantele, Tinja Lääveri, Juha Kirveskari, Jenni Antikainen, Jussi M. Kantele, Sointu Mero, Jukka Ollgren, Hannu Järveläinen, Renato V. Iozzo and Eric L. Brown and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Sari H. Pakkanen

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sari H. Pakkanen Finland 19 488 357 255 250 196 40 1.3k
Juha Kirveskari Finland 25 531 1.1× 385 1.1× 356 1.4× 228 0.9× 222 1.1× 53 1.7k
Hiroshi Watanabe Japan 23 475 1.0× 153 0.4× 143 0.6× 44 0.2× 417 2.1× 131 1.8k
Stephen Morris‐Jones United Kingdom 24 530 1.1× 487 1.4× 47 0.2× 77 0.3× 239 1.2× 67 1.6k
Yong Chong Japan 24 353 0.7× 59 0.2× 218 0.9× 43 0.2× 354 1.8× 107 1.9k
Timothy Blackmore New Zealand 19 374 0.8× 195 0.5× 125 0.5× 28 0.1× 171 0.9× 43 1.5k
Mark P. Simons United States 17 248 0.5× 105 0.3× 86 0.3× 70 0.3× 206 1.1× 46 884
H.A. Verbrugh Netherlands 15 583 1.2× 102 0.3× 48 0.2× 153 0.6× 295 1.5× 21 1.1k
Larry I. Lutwick United States 21 527 1.1× 209 0.6× 93 0.4× 26 0.1× 220 1.1× 85 1.6k
Eduardo López Argentina 25 608 1.2× 65 0.2× 548 2.1× 96 0.4× 106 0.5× 85 1.7k
Clara Larcher Austria 26 445 0.9× 109 0.3× 136 0.5× 34 0.1× 203 1.0× 79 1.8k

Countries citing papers authored by Sari H. Pakkanen

Since Specialization
Citations

This map shows the geographic impact of Sari H. Pakkanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sari H. Pakkanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sari H. Pakkanen more than expected).

Fields of papers citing papers by Sari H. Pakkanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sari H. Pakkanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sari H. Pakkanen. The network helps show where Sari H. Pakkanen may publish in the future.

Co-authorship network of co-authors of Sari H. Pakkanen

This figure shows the co-authorship network connecting the top 25 collaborators of Sari H. Pakkanen. A scholar is included among the top collaborators of Sari H. Pakkanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sari H. Pakkanen. Sari H. Pakkanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Virtanen, Jenni, Sari H. Pakkanen, Jussi Hepojoki, et al.. (2024). Convalescent plasma therapy for COVID-19 – Donor selection strategies and establishment of a plasma bank. New Microbes and New Infections. 62. 101525–101525. 1 indexed citations
2.
3.
Virtanen, Jenni, Ruut Uusitalo, Essi M. Korhonen, et al.. (2021). Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays. Viruses. 13(6). 996–996. 7 indexed citations
4.
Kareinen, Lauri, Lev Levanov, Sointu Mero, et al.. (2021). A 10-Minute “Mix and Read” Antibody Assay for SARS-CoV-2. Viruses. 13(2). 143–143. 17 indexed citations
5.
Pekkarinen, Pirkka T., Kirsten Nowlan, Suvi Kuivanen, et al.. (2021). Characterization of low-density granulocytes in COVID-19. PLoS Pathogens. 17(7). e1009721–e1009721. 59 indexed citations
6.
Lääveri, Tinja, Jenni Antikainen, Sointu Mero, et al.. (2020). Bacterial, viral and parasitic pathogens analysed by qPCR: Findings from a prospective study of travellers’ diarrhoea. Travel Medicine and Infectious Disease. 40. 101957–101957. 13 indexed citations
7.
Kantele, Anu, Tinja Lääveri, Lauri Kareinen, et al.. (2020). SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors. Travel Medicine and Infectious Disease. 39. 101949–101949. 30 indexed citations
8.
Lääveri, Tinja, et al.. (2018). Despite antibiotic treatment of travellers' diarrhoea, pathogens are found in stools from half of travellers at return. Travel Medicine and Infectious Disease. 23. 49–55. 11 indexed citations
9.
Lääveri, Tinja, et al.. (2018). Stand-by antibiotics encourage unwarranted use of antibiotics for travelers’ diarrhea: A prospective study. Travel Medicine and Infectious Disease. 27. 64–71. 25 indexed citations
10.
Lääveri, Tinja, Sari H. Pakkanen, Juha Kirveskari, & Anu Kantele. (2018). Travellers' diarrhoea: Impact of TD definition and control group design on study results. Travel Medicine and Infectious Disease. 24. 37–43. 15 indexed citations
11.
Lääveri, Tinja, et al.. (2017). A prospective study of travellers' diarrhoea: analysis of pathogen findings by destination in various (sub)tropical regions. Clinical Microbiology and Infection. 24(8). 908.e9–908.e16. 41 indexed citations
12.
Pakkanen, Sari H., et al.. (2016). Travelers’ health problems and behavior: prospective study with post-travel follow-up. BMC Infectious Diseases. 16(1). 328–328. 71 indexed citations
13.
Lääveri, Tinja, Jenni Antikainen, Sari H. Pakkanen, Juha Kirveskari, & Anu Kantele. (2016). Prospective study of pathogens in asymptomatic travellers and those with diarrhoea: aetiological agents revisited. Clinical Microbiology and Infection. 22(6). 535–541. 48 indexed citations
14.
15.
16.
Kantele, Anu, Tinja Lääveri, Sointu Mero, et al.. (2015). Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae. Clinical Infectious Diseases. 60(6). 837–846. 217 indexed citations
17.
18.
Pakkanen, Sari H., Jussi M. Kantele, & Anu Kantele. (2012). Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination. Vaccine. 30(42). 6047–6053. 36 indexed citations
19.
Erra, Elina, Helena Hervius Askling, Lars Rombo, et al.. (2012). A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines. Clinical Infectious Diseases. 55(6). 825–834. 28 indexed citations
20.
Koskivirta, Ilpo, Otto Rahkonen, Mikko I. Mäyränpää, et al.. (2006). Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology. Histochemistry and Cell Biology. 126(3). 335–342. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juha Kirveskari Breakdown of academic impact, for papers by Hiroshi Watanabe Breakdown of academic impact, for papers by Stephen Morris‐Jones Breakdown of academic impact, for papers by Yong Chong Breakdown of academic impact, for papers by Timothy Blackmore Breakdown of academic impact, for papers by Mark P. Simons Breakdown of academic impact, for papers by H.A. Verbrugh Breakdown of academic impact, for papers by Larry I. Lutwick Breakdown of academic impact, for papers by Eduardo López Breakdown of academic impact, for papers by Clara Larcher
Rankless by CCL
2026